Extrapyramidal Symptoms with Selective Serotonin Reuptake Inhibitors
- 1 December 1994
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 165 (6) , 728-733
- https://doi.org/10.1192/bjp.165.6.728
Abstract
Background: Several case reports in the literature suggest that selective serotonin reuptake inhibitors can produce extrapyramidal symptoms.Method: Computerised literature searches were used to identify reports on extrapyramidal symptoms and serotonin reuptake inhibitors. Subsequently, manual searches were made for articles in which there was any indication of the mechanisms responsible for these extrapyramidal symptoms.Results: Only a few reports could be identified in which serotonin reuptake inhibitors were implicated in extrapyramidal symptoms in some patients.Conclusions: Evidence is discussed from preclinical and clinical studies suggesting the interaction between serotoninergic and dopaminergic neurotransmitter system, as a possible mechanism for production of extrapyramidal symptoms.Keywords
This publication has 77 references indexed in Scilit:
- Extrapyramidal symptoms in a patient treated with fluvoxamine.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Extrapyramidal reaction to ondansetronCancer, 1992
- A case of Parkinson's disease exacerbated by fluoxetineHuman Psychopharmacology: Clinical and Experimental, 1992
- Effects of mianserin in neuroleptic-induced parkinsonismPsychopharmacology, 1986
- Behavioral aspects of serotonin-dopamine interaction in the monkeyEuropean Journal of Pharmacology, 1985
- Noradrenaline and 5‐hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease.British Journal of Clinical Pharmacology, 1983
- Inhibition of the electrically induced release of [3H]dopamine by serotonin from superfused rat striatal slicesNeuroscience Letters, 1982
- Neuroleptic-induced acute dyskinesias in rhesus monkeysPsychopharmacology, 1981
- Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressantJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1979
- Serotonin-dopamine interactions in the nigrostriatal systemEuropean Journal of Pharmacology, 1979